1.Takeuchi H, Miyamoto T, Fuseya C, Asaka R, Ida K, Ono M, Tanaka Y, Shinagawa M, Ando H, Asaka S, Shiozawa T.
PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium
Int J Gynecol Pathol42(3):282-292,2023
2.Ono M, Miyamoto T, Fuseya C, Asaka R, Ando H, Tanaka Y, Shinagawa M, Yokokawa Y, Takeuchi H, Horiuchi A, Shiozawa T
Anti‐tumor effect of Wasabi component, 6‐(methylsulfnyl) hexyl isothiocyanate, against endometrial carcinoma cells.
Discover Oncol. 14(1):9,2023
3.Y U Lu, Tsutomu Miyamoto , Hodaka Takeuchi , Fumi Tsunoda , Naoki Tanaka , Tanri Shiozawa
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A
Oncol Res.31(3):239-253,2023
4.Okumura T, Noguchi T, Sekiguchi N, Kobayashi T, Kanda S, Ida K, Minagawa T, Tokumaru S, Umemura T, Koizumi T.
Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
Chemotherapy. 68(2):87-94,2023
5.Ono M,Miyamoto T,Asaka R,uchikawa J,ando H,Tanaka Y,Shinagawa M,Yokokawa Y,Asaka S,Wang TL,Shin IM,Shiozawa T.
Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
Sci Rep.13(1):8348,2023
6. Kobayashi S, Biyajima K, Matsuzawa S, Sakai K, Kawakami F, Kawakami T, Nishina S, Sakai H, Fuseya C, Nakazawa H
Acute leukemias in pregnant women: Results of a retrospective study at a local tertiary-care hospital in Japan
EJHaem;4(2):393-400,2023
7.Asaka S, Liu Y, Yu ZC, Rahmanto YS, Ono M, Asaka R, Miyamoto T, Yen TT, Ayhan A, Wang TL, Shih IM
ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis
Mod Pathol;36(2):100045,2023
8.Zhang C, Hoang G, Attarwala N, Cooper AJL, Asaka R, Le A.
Metabolic Recycling Enhances Proliferation in MYC-Transformed Lymphoma B Cells
Adv Biol (Weinh);7(2):e2200233,2023
